A. Czibere

Sorafenib (Nexavar) induces molecular remission and regression of extramedullary disease in a patient with FLT3-ITD+ acute myeloid leukemia.

I. Bruns, G. Kobbe, R. Fenk, 2009, Leukemia research.

Pegfilgrastim for PBSC mobilization and autologous haematopoietic SCT

I. Bruns, G. Kobbe, R. Fenk, 2009, Bone Marrow Transplantation.

Fludarabine, amsacrine, high-dose cytarabine and 12 Gy total body irradiation followed by allogeneic hematopoietic stem cell transplantation is effective in patients with relapsed or high-risk acute lymphoblastic leukemia

I. Bruns, G. Kobbe, R. Fenk, 2009, Bone Marrow Transplantation.

Azacitidine and donor lymphocyte infusions as first salvage therapy for relapse of AML or MDS after allogeneic stem cell transplantation

N. Kröger, T. Luft, I. Bruns, 2013, Leukemia.

The Mexican Way: a feasible approach to avoid DMSO toxicity

I. Bruns, G. Kobbe, R. Fenk, 2011, Bone Marrow Transplantation.

Tacrolimus and mycofenolate mofetil as GvHD prophylaxis following nonmyeloablative conditioning and unrelated hematopoietic SCT for adult patients with advanced hematologic diseases

I. Bruns, G. Kobbe, R. Fenk, 2011, Bone Marrow Transplantation.

Bendamustine in patients with relapsed or refractory multiple myeloma

I. Bruns, G. Kobbe, R. Fenk, 2010, European journal of medical research.